Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Robert Jones

Dermatology Jackson, TN Medical Doctor

NPI 1295788461 CMS profile 195164

1320 Union University Dr, Jackson, TN 38305

Open in the dashboard

General payments

$4,367

257 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Through program year 2021, Robert Jones of Jackson, TN is reported in the CMS Open Payments database as having received $4,367 across 257 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 62nd percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $441 25
2020 General $1,391 81
2019 General $2,534 151

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Jones
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Robert Jones were reported at $0. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Robert Jones Dermatology median Middle half National median
2019 $2,534 $454 $129–$1,240 $163
2020 $1,391 $235 $81–$756 $114
2021 $441 $377 $108–$1,108 $132
2022 $0 $514 $143–$1,391 $149
2023 $0 $607 $159–$1,674 $160
2024 $0 $751 $204–$1,903 $164
2025 $0 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. AbbVie, Inc. $1,421 60 payments
  2. Mayne Pharma Inc. $476 46 payments
  3. Novartis Pharmaceuticals Corporation $428 15 payments
  4. Janssen Biotech, Inc. $409 27 payments
  5. Lilly USA, LLC $343 22 payments
  6. Amgen Inc. $199 13 payments
  7. Celgene Corporation $185 17 payments
  8. Sun Pharmaceutical Industries Inc. $178 11 payments
  9. LEO Pharma Inc. $162 11 payments
  10. Genzyme Corporation $107 6 payments
  11. Other $458 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Food and Beverage $4,367 257 payments
Products named General payments · program years 2019–2021
  1. HUMIRA $970 47 payments
  2. SKYRIZI $791 33 payments
  3. STELARA $391 26 payments
  4. COSENTYX $359 11 payments
  5. TALTZ $343 22 payments
  6. DORYX $321 34 payments
  7. SIMPONI ARIA $269 18 payments
  8. REMICADE $269 18 payments
  9. SIMPONI $269 18 payments
  10. Otezla $179 12 payments
  11. Other $1,331 86 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

257 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record